CirChem AB (publ) (STO:CIRCHE)
0.6620
+0.0080 (1.22%)
Aug 14, 2026, 12:10 PM CET
CirChem AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4.11 | 9.96 | 20.66 | 5.75 | 0.59 | 0.09 |
Other Revenue | 0.28 | 0.32 | 1.18 | - | - | - |
| 4.39 | 10.28 | 21.84 | 5.75 | 0.59 | 0.09 | |
Revenue Growth | -84.58% | -52.94% | 280.19% | 872.72% | 590.35% | 16.88% |
Cost of Revenue | 17.57 | 17.41 | 19.22 | 14.18 | 8.81 | 4.81 |
Gross Profit | -13.18 | -7.13 | 2.62 | -8.44 | -8.22 | -4.72 |
Selling, General & Admin | 7.83 | 7.98 | 7.48 | 8.28 | 15.16 | 14.81 |
Other Operating Expenses | -5.18 | -5.02 | -5.12 | -1.15 | -3.52 | -2.8 |
Operating Expenses | 3.78 | 4.08 | 2.51 | 7.18 | 11.72 | 12.09 |
Operating Income | -16.96 | -11.2 | 0.1 | -15.62 | -19.94 | -16.81 |
Interest Expense | -1.18 | -0.86 | -1.29 | -1.58 | -2.76 | -1.33 |
Interest & Investment Income | 0.01 | 0.01 | 0.11 | 0.06 | 0 | - |
Currency Exchange Gain (Loss) | - | - | - | -0.01 | -0.02 | -0.01 |
Other Non Operating Income (Expenses) | -0 | - | - | - | - | - |
Pretax Income | -18.13 | -12.05 | -1.07 | -17.14 | -22.72 | -18.15 |
Net Income | -18.13 | -12.05 | -1.07 | -17.14 | -22.72 | -18.15 |
Net Income to Common | -18.13 | -12.05 | -1.07 | -17.14 | -22.72 | -18.15 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 40 | 37 | 30 | 27 | 16 | 13 |
Shares Outstanding (Diluted) | 40 | 37 | 30 | 27 | 16 | 13 |
Shares Change | 23.87% | 21.77% | 13.31% | 66.51% | 25.09% | 27.33% |
EPS (Basic) | -0.45 | -0.33 | -0.04 | -0.64 | -1.42 | -1.42 |
EPS (Diluted) | -0.45 | -0.33 | -0.04 | -0.64 | -1.42 | -1.42 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -17.08 | -20.58 | -12.85 | -27.48 | -25.27 | -5.47 |
Free Cash Flow Per Share | -0.43 | -0.56 | -0.43 | -1.03 | -1.58 | -0.43 |
Gross Margin | - | -69.31% | 11.99% | -146.88% | - | - |
Operating Margin | -386.31% | -108.96% | 0.48% | -271.80% | -3375.93% | -19650.43% |
Profit Margin | -413.07% | -117.22% | -4.90% | -298.36% | -3846.65% | -21215.45% |
Free Cash Flow Margin | -389.11% | -200.15% | -58.84% | -478.31% | -4277.82% | -6389.62% |
EBITDA | -15.84 | -10.08 | 0.26 | -15.57 | -19.86 | -16.73 |
EBITDA Margin | - | -98.06% | 1.20% | -270.93% | - | - |
D&A For EBITDA | 1.12 | 1.12 | 0.16 | 0.05 | 0.08 | 0.08 |
EBIT | -16.96 | -11.2 | 0.1 | -15.62 | -19.94 | -16.81 |
EBIT Margin | - | -108.96% | 0.48% | -271.80% | - | - |
Revenue as Reported | 9.69 | 15.58 | 27.02 | 6.9 | 4.11 | 2.89 |